Skip to main content

Table 2 In silico predictions for the CRYAA variants

From: Expanding the phenotype of CRYAA nucleotide variants to a complex presentation of anterior segment dysgenesis

Variant

Inheritance

gnomAD Freq

ACMG classification (criteria)

GERP

PhyloP100

CADD

DANN

FATHMM-MKL

Mutation

Taster

Eigen

In silico splicing prediction

SIFT

Align

GV-GD

c.520T > C; p.(*174Glnext*41)

de novo

None

Likely pathogenic (PM2, PM4, PP3, PS2)

3.7899

2.87

15.34

0.8224

P

(0.7147)

B

P

(0.6226)

No effect on splicing

NA

NA

c.521A > C; p.(*174Serext*41)

de novo

None

Likely pathogenic (PM2, PM4, PP3, PS2)

3.7899

2.963

14.26

0.6924

P

(0.7147)

B

P

(0.6226)

No effect on splicing

NA

NA

  1. Notes: Variants were numbered according to RefSeq transcript NM_000394.4 for CRYAA.
  2. B benign, NA not available, P pathogenic